PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION ...
AB Science receives US patent for masitinib to treat sickle cell disease: Paris Friday, December 26, 2025, 14:00 Hrs [IST] AB Science SA, a pharmaceutical company specializing in ...
During a live event, Kathryn E. Beckermann, MD, PhD, and participants discussed whether risk stratification factors into the ...
News-Medical.Net on MSN
Prebiotic microcapsules deliver pterostilbene to the colon to alleviate ulcerative colitis
A team led by clinicians and engineers has wrapped the plant-derived polyphenol pterostilbene (PSB) into prebiotic ...
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells ...
When Leslie Keebler contracted the flu last winter, early-stage lung cancer was not on her radar. The 62-year-old from ...
Lung health is vital for overall well-being, especially given the increasing levels of pollution and respiratory challenges worldwide. Our lungs constantly filter the air, but they can accumulate ...
Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD" has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback